Drug Trial Radar · NCT07075224
Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution
Last checked: Nov 19, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Nov 1, 2025
Primary completion
Nov 9, 2025
Study completion Nov 12, 2025
Sponsor
- Lead sponsor
- Unither Pharmaceuticals, FranceIndustry
- Sponsor type
- Industry
- First posted
- Jul 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to explore pharmacodynamic effects and safety of IMP 08P2002F0 for dilation of the pupil, a solution combining two mydriatic agents tropicamide and phenylephrine hydrochloride at the concentrations of 0.34% and 2.5% respectively, versus Mydriasert®
Conditions
- Mydriasis
Interventions
IMP 08P2002F0Drug
Fixed combination of 0.34 % tropicamide and 2.5 % phenylephrine Hydrochloride (HCl) Eye drop Solution.
Mydriasert® insertDrug
0.28 mg tropicamide and 5.4 mg phenylephrine hydrochloride
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pupil Diameter at 60 Minutes From the Time of First Dose Versus Baseline, as Measured With Photo (Central Reading)Time frame: 60 minutes
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Ophthalmiatreion Athinon
Athens, Greece
Iaso Thessalia General Clinic Private Obstetrics S.A.
Larissa, Greece
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.